Personas / Equipo Humano

Manuel Vázquez Carrera

Buscador de publicaciones

Publicaciones

  • Sanguino E, Roglans N, Alegret M, Sánchez RM, Vazquez M and Laguna JC.

    Prevention of age-related changes in rat cortex transcription factor activator protein-1 by hypolipidemic drugs.

    BIOCHEMICAL PHARMACOLOGY . 68(7): 1411-1421. Nº de citas: 16

    [doi:10.1016/j.bcp.2004.06.008]

  • Sanguino E, Bejarano R, Alegret M, Sánchez RM, Vazquez M and Laguna JC.

    Sexual dimorphism in lipid metabolic phenotype associated with old age in Sprague-Dawley rats.

    EXPERIMENTAL GERONTOLOGY . 39(9): 1295-1306. Nº de citas: 18

    [doi:10.1016/j.exger.2004.06.007]

  • Vazquez M and Silvestre JS.

    Insulin analogues in the management of diabetes.

    Methods And Findings In Experimental And Clinical Pharmacology . 26(6): 445-461. Nº de citas: 26

  • Llaverias G, Lacasa D, Viñals M, Vazquez M, Sánchez RM, Laguna JC and Alegret M.

    Reduction of intracellular cholesterol accumulation in THP-1 macrophages by a combination of rosiglitazone and atorvastatin.

    BIOCHEMICAL PHARMACOLOGY . 68(1): 155-163. Nº de citas: 29

    [doi:10.1016/j.bcp.2004.03.009]

  • Llaverias G, Noé V, Peñuelas S, Vazquez M, Sánchez RM, Laguna JC, Ciudad CJ and Alegret M.

    Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages.

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS . 318(1): 265-274. Nº de citas: 66

    [doi:10.1016/j.bbrc.2004.04.021]

  • Roglans N, Vazquez M, Alegret M, Novell F, Zambón D, Ros E, Laguna JC and Sánchez RM.

    Fibrates modify the expression of key factors involved in bile-acid synthesis and biliary-lipid secretion in gallstone patients.

    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY . 59(12): 855-861. Nº de citas: 54

    [doi:10.1007/s00228-003-0704-1]

  • Jové M, Salla J, Planavila A, Cabrero A, Michalik L, Wahli W, Laguna JC and Vazquez M.

    Impaired expression of NADH dehydrogenase subunit 1 and PPARgamma coactivator-1 in skeletal muscle of ZDF rats: restoration by troglitazone.

    JOURNAL OF LIPID RESEARCH . 45(1): 113-123. Nº de citas: 51

    [doi:10.1194/jlr.M300208-JLR200]

  • Planavila A, Jové M, Cabrero A and Vazquez M.

    Modula el metabolismo lipídico del miocardio la hipertrofia cardíaca?

    Nefrologia . 24 Suppl 4: 29-33.

  • Sanguino E, Ramón M, Michalik L, Wahli W, Alegret M, Sánchez RM, Vazquez M and Laguna JC.

    Lack of hypotriglyceridemic effect of gemfibrozil as a consequence of age-related changes in rat liver PPARalpha.

    BIOCHEMICAL PHARMACOLOGY . 67(1): 157-166. Nº de citas: 34

    [doi:10.1016/j.bcp.2003.08.034]

  • Sanguino E, Ramón M, Roglans N, Alegret M, Sánchez RM, Vazquez M and Laguna JC.

    Gemfibrozil increases the specific binding of rat-cortex nuclear extracts to a PPRE probe.

    LIFE SCIENCES . 73(23): 2927-2937. Nº de citas: 9

    [doi:10.1016/j.lfs.2003.04.001]